Alnylam Pharmaceuticals | Fremdkapital



Loan Capital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amgen USD 54.01B 2.54B 2025-03
Arrowhead Research USD 407.79M 14.61M 2024-12
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
Incyte USD 32.64M 899K 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
Moderna USD 35M 4M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
PTC Therapeutics USD 2.12B 179K 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Sanofi 11.79B 712M 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Takeda JPY 3.97T 738.36B 2025-03
Tectonic Therapeutic USD 387K 126K 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Xencor USD 115.16M 104.99M 2024-12



Alnylam Pharmaceuticals Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.